ArticleBipolar disorders2026
Association Between Lithium Use and Suicide-Related Behaviors in Bipolar Disorder: A Multicenter Study.
Article in Bipolar disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors.
Funding
Abstract
backgroundLithium has long been associated with reduced suicide risk in bipolar disorder; however, evidence from real-world clinical populations remains susceptible to confounding, and the behavioral correlates related to this association are not well characterized.
methodsIn this multicenter cross-sectional study, 616 individuals aged 12-45 years with bipolar disorder were recruited from 14 psychiatric centers, of whom 585 had complete data for the present analyses. Lithium exposure within the past year was determined from clinical records. The primary outcome was a composite of suicide-related behaviors, including suicidal ideation, suicide attempts, and non-suicidal self-injury. A pre-specified analytical framework was applied, with multivariable logistic regression as the primary analysis and propensity score matching (PSM) as the principal approach to improve covariate balance. Regression-based decomposition analyses were conducted to examine whether aggression was statistically associated with the exposure-outcome relationship, and restricted cubic spline models were used to characterize the dose-response association between aggression and suicide-related behaviors. Robustness analyses included inverse probability of treatment weighting (IPTW), alternative matching specifications, E-value analyses, cluster-robust standard errors, and exploratory age-stratified analyses.
resultsLithium exposure was associated with lower odds of suicide-related behaviors in both the fully adjusted model (OR = 0.55, 95% CI: 0.34-0.89) and the propensity score-matched sample (OR = 0.53, 95% CI: 0.33-0.86). Higher aggression scores were linearly associated with increased suicide-related risk. Exploratory regression-based decomposition analyses indicated that approximately 20.93% of the observed lithium-outcome association was statistically accounted for by aggression. Results from robustness analyses were directionally consistent with the primary findings.
conclusionsIn this multicenter clinical sample, lithium exposure was consistently associated with lower odds of suicide-related behaviors across multiple analytic approaches. Aggression was independently associated with suicide-related risk and statistically accounted for part of the observed association between lithium exposure and suicide-related outcomes. However, causal inference is limited by the cross-sectional design, and residual confounding-particularly confounding by indication-remains a key concern. Prospective longitudinal studies are required to clarify temporal relationships and disentangle treatment effects from selection processes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.